Treatment

SNDX-5613 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias
This study looks at a new drug, SNDX-5613, combined with standard chemotherapy for a type of blood cancer called Acute Myeloid Leukemia (AML). It aims to see how safe and effective this new combination is for people whose AML has specific genetic changes.
For: Acute Myeloid Leukemias
United States · Australia · Canada